Tolvaptan in autosomal dominant polycystic kidney disease

N Engl J Med. 2013 Mar 28;368(13):1257-8. doi: 10.1056/NEJMc1300762.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antidiuretic Hormone Receptor Antagonists*
  • Benzazepines / therapeutic use*
  • Female
  • Humans
  • Kidney / pathology*
  • Male
  • Polycystic Kidney, Autosomal Dominant / drug therapy*

Substances

  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines